Why the study?
Does administration of AAV vectors predispose mice to liver tumors?
Population
921 C57BL/6 mice (695 treated, 226 controls)
Comparison
Adeno-associated virus vectors, mostly via… vs Control mice (n=226)
Design
Preclinical
Authors
Loading...
Supports AAV safety in mice; leaves open human tumorigenicity assessment in gene therapy.
Does administration of AAV vectors predispose mice to liver tumors?
AAV vectors do not appear to predispose mice to liver tumorigenesis, supporting their safety profile for gene therapy applications.
Bell et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: